Company Overview and News
LONDON (Reuters) - New U.S. liquefied natural gas terminals with enough capacity to double U.S. exports have either begun commissioning their facilities or are waiting for approval from the energy regulator, a review of their documents showed this week.
CQP KMI LNG KMR KMRFZ CVB
NEW YORK, Sept 19 — China set a 10 per cent tariff on US liquefied natural gas (LNG) imports, extending a trade dispute into energy and casting a shadow over US export terminals that would propel the United States into the world's second-largest LNG seller.
LNGLF CQP XOM LNG GLNG LNGLY KMI TRI KMR CVB KMRFZ LNG
NEW YORK/LONDON (Reuters) - China set a 10 percent tariff on U.S. liquefied natural gas (LNG) imports, extending a trade dispute into energy and casting a shadow over U.S. export terminals that would propel the United States into the world’s second-largest LNG seller.
LNGLF CQP LNG XOM GLNG LNGLY KMI KMR CVB KMRFZ LNG
LONDON (Sept 18): China set a tariff on US liquefied natural gas (LNG), casting a shadow over US plans for new export terminals that were expected to turn the United States into the world's second largest LNG seller.
CQP KMI LNG TRI GLNG KMR CVB KMRFZ
LONDON (Reuters) - China set a tariff on U.S. liquefied natural gas (LNG), casting a shadow over U.S. plans for new export terminals that were expected to turn the United States into the world’s second largest LNG seller.
CQP KMI LNG GLNG KMR CVB KMRFZ LNG
(Bloomberg) -- China plans to slap tariffs on U.S. natural gas exports as trade tensions escalate, a likely setback for the burgeoning energy relationship between the world’s two largest economies.
LNGLF CQP DSLV VIIX DGLD LNG CSSLF VIIZ CS CSGKF UGLD LNGLY ZIV USLV TVIX LNG XIV
(Reuters) - China has set a 10 percent tariff on imports of U.S. liquefied natural gas just as trade of the super-chilled fuel between the two nations started to ramp up and exports from new terminals on the U.S. Gulf Coast are poised to begin.
CQP KMI LNG KMR KMRFZ CVB
A subsidiary of Cheniere Energy, Inc. (LNG - Free Report) , Cheniere Marketing, LLC, has inked a 15-year sale and purchase agreement (“SPA”) with Vitol Inc. Per the agreement, Vitol will purchase about 0.7 million tons per annum of liquefied natural gas (“LNG”) from Cheniere Marketing on a free-on-board basis starting in 2018. The purchase price for LNG is indexed to the monthly Henry Hub price, which includes a fee.
HLX TCP CQP TXN LNG MDPEB MDP LNG
The U.S. Energy Department's weekly inventory release showed a marginally smaller-than-expected increase in natural gas supplies. Despite the headline beat and a growing storage deficit, strong production and the expected power loss from Hurricane Florence weighed on the fuel’s price, which ended flat over the week.
ECR CKRGZ CQP LNG CHKVP CRK COG SBOW CHKDH CHKVZ CHKDG CHKWZ CHKDJ CHKDP CHK CHK.WI GPOR
(Reuters) - U.S.-based Cheniere Energy Inc said on Monday that it has signed a 15-year agreement to supply liquefied natural gas (LNG) to the world’s largest oil trader Vitol Group that has been steadily ramping up its presence in that market.
BARCELONA, Spain, Sept 17 (Reuters) - Global trade volumes for liquefied natural gas (LNG) could double in the coming years, Vitol’s chief executive said after the commodity merchant announced a long-term deal to buy the fuel from U.S. producer Cheniere Energy.
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
2018-09-18 - Asif
Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...
2018-09-18 - Asif
Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...
Silicon Investor Message Boards
This table lists all message boards related to LNG / Cheniere Energy, Inc. on message board site Silicon Investor.
|Shipping - Oil u0026 Gas Tankers, Dry cargo, LNG||Shipping - Oil u0026 Gas Tankers, Dry cargo, LNG||Shipping - Oil u0026 Gas Tankers, Dry cargo, LNG||Golar LNG Limited||Golar LNG Limited||Golar LNG Limited|
as of ET